1 – 19 of 19
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Physics for molecular radiotherapy – The battle between science and simplicity
(
- Contribution to journal › Debate/Note/Editorial
- 2023
-
Mark
EFOMP policy statement NO. 19 : Dosimetry in nuclear medicine therapy – Molecular radiotherapy
(
- Contribution to journal › Scientific review
-
Mark
Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry
(
- Contribution to journal › Debate/Note/Editorial
- 2021
-
Mark
EANM dosimetry committee series on standard operational procedures : a unified methodology for 99mTc-MAA pre- and 90Y peri-therapy dosimetry in liver radioembolization with 90Y microspheres
(
- Contribution to journal › Article
- 2018
-
Mark
EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations
(
- Contribution to journal › Article
- 2017
-
Mark
The potential of 223Ra and 18F-fluoride imaging to predict bone lesion response to treatment with 223Ra-dichloride in castration-resistant prostate cancer
(
- Contribution to journal › Article
-
Mark
Comparison of Empiric Versus Dosimetry-Guided Radioiodine Therapy : The Devil Is in the Details
(
- Contribution to journal › Article
-
Mark
Variations in the practice of molecular radiotherapy and implementation of dosimetry : results from a European survey
(
- Contribution to journal › Article
-
Mark
Dosimetry-based treatment planning for molecular radiotherapy : A summary of the 2017 report from the Internal Dosimetry Task Force
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Biologically effective dose in fractionated molecular radiotherapy-application to treatment of neuroblastoma with (131)I-mIBG.
(
- Contribution to journal › Article
-
Mark
Whole-remnant and maximum-voxel SPECT/CT dosimetry in 131I-NaI treatments of differentiated thyroid cancer
(
- Contribution to journal › Article
- 2015
-
Mark
Dosimetric results in treatments of neuroblastoma and neuroendocrine tumors with (131)I-metaiodobenzylguanidine with implications for the activity to administer.
(
- Contribution to journal › Article
-
Mark
A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of Ra-223-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases
(
- Contribution to journal › Article
- 2012
-
Mark
Quantitative imaging of 223Ra-chloride (Alpharadin) for targeted alpha-emitting radionuclide therapy of bone metastases.
(
- Contribution to journal › Article
- 2011
-
Mark
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds
(
- Contribution to journal › Article
- 2010
-
Mark
EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry
(
- Contribution to journal › Article
- 2007
-
Mark
Optimization of energy-window settings for scatter correction in quantitative In-111 imaging: Comparison of measurements and Monte Carlo simulations
(
- Contribution to journal › Article
-
Mark
Single-cell dosimetry for radioimmunotherapy of B-cell lymphoma patients with special reference to leukemic spread
(
- Contribution to journal › Article
- 2006
-
Mark
Quantitative imaging for clinical dosimetry
2006) In Nuclear Instruments & Methods in Physics Research. Section A: Accelerators, Spectrometers, Detectors, and Associated Equipment 569(2). p.467-471(
- Contribution to journal › Article